{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T23:04:14Z","timestamp":1784934254641,"version":"3.55.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T00:00:00Z","timestamp":1588032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s11096-020-01038-9","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T02:02:44Z","timestamp":1588039364000},"page":"956-964","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Effects of red blood cell concentrate transfusion on blood tacrolimus concentration"],"prefix":"10.1007","volume":"42","author":[{"given":"Masashi","family":"Uchida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Yamazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirokazu","family":"Takatsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itsuko","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,28]]},"reference":[{"key":"1038_CR1","first-page":"2303","volume":"92","author":"V Ratanatharathorn","year":"1998","unstructured":"Ratanatharathorn V, Nash RA, Przepiorka D, Devine SM, Klein JL, Weisdorf D, et al. Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation. Blood. 1998;92:2303\u201314.","journal-title":"Blood"},{"key":"1038_CR2","first-page":"2062","volume":"96","author":"RA Nash","year":"2000","unstructured":"Nash RA, Antin JH, Karanes C, Fay JW, Avalos BR, Yeager AM, et al. Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors. Blood. 2000;96:2062\u20138.","journal-title":"Blood"},{"key":"1038_CR3","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/sj.bmt.1703097","volume":"28","author":"A Hiraoka","year":"2001","unstructured":"Hiraoka A, Ohashi Y, Okamoto S, Moriyama Y, Nagao T, Kodera Y, Japanese FK506 BMT(Bone Marrow Transplantation) Study Group, et al. Phase III study comparing tacrolimus (FK506) with cyclosporine for graft-versus-host disease prophylaxis after allogeneic bone marrow transplantation. Bone Marrow Transpl. 2001;28:181\u20135.","journal-title":"Bone Marrow Transpl"},{"key":"1038_CR4","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s12185-015-1784-2","volume":"101","author":"M Murata","year":"2015","unstructured":"Murata M. Prophylactic and therapeutic treatment of graft-versus-host disease in Japan. Int J Hematol. 2015;101:467\u201386.","journal-title":"Int J Hematol"},{"key":"1038_CR5","first-page":"2753","volume":"23","author":"M Machida","year":"1991","unstructured":"Machida M, Takahara S, Ishibashi M, Hayashi M, Sekihara T, Yamanaka H. Effect of temperature and hematocrit on plasma concentration of FK 506. Transplant Proc. 1991;23:2753\u20134.","journal-title":"Transplant Proc"},{"key":"1038_CR6","volume-title":"Guidelines on TDM of immunosuppressive drugs in organ transplantation","author":"The Japanese Society of Therapeutic Drug Monitoring and the Japanese Society of Transplantation","year":"2014","unstructured":"The Japanese Society of Therapeutic Drug Monitoring and the Japanese Society of Transplantation. Guidelines on TDM of immunosuppressive drugs in organ transplantation. 1st ed. Tokyo: Kanehara Publishing Ltd.; 2014.","edition":"1"},{"issue":"6244","key":"1038_CR7","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1038\/341755a0","volume":"341","author":"JJ Siekierka","year":"1989","unstructured":"Siekierka JJ, Hung SH, Poe M, Lin CS, Sigal NH. A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. Nature. 1989;341(6244):755\u20137.","journal-title":"Nature"},{"key":"1038_CR8","first-page":"2760","volume":"23","author":"JE Kay","year":"1991","unstructured":"Kay JE, Sampare-Kwateng E, Geraghty F, Morgan GY. Uptake of FK 506 by lymphocytes and erythrocytes. Transplant Proc. 1991;23:2760\u20132.","journal-title":"Transplant Proc"},{"key":"1038_CR9","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1006\/bbrc.1995.2455","volume":"215","author":"EB Cunningham","year":"1995","unstructured":"Cunningham EB. The human erythrocyte membrane contains a novel 12-kDa inositolphosphate-binding protein that is an immunophilin. Biochem Biophys Res Commun. 1995;215:212\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"1038_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1056-8719(02)00158-2","volume":"46","author":"H Zahir","year":"2001","unstructured":"Zahir H, Nand RA, Brown KF, Tattam BN, McLachlan AJ. Validation of methods to study the distribution and protein binding of tacrolimus in human blood. J Pharmacol Toxicol Methods. 2001;46:27\u201335.","journal-title":"J Pharmacol Toxicol Methods"},{"key":"1038_CR11","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/S0041-1345(98)00234-6","volume":"30","author":"NA Undre","year":"1998","unstructured":"European Tacrolimus Multicentre Renal Study Group, Undre NA, Sch\u00e4fer A. Factors affecting the pharmacokinetics of tacrolimus in the first year after renal transplantation. Transplant Proc. 1998;30:1261\u20133.","journal-title":"Transplant Proc"},{"key":"1038_CR12","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1016\/j.transproceed.2004.04.097","volume":"36","author":"T Minematsu","year":"2004","unstructured":"Minematsu T, Sugiyama E, Kusama M, Hori S, Yamada Y, Ohtani H, et al. Effect of hematocrit on pharmacokinetics of tacrolimus in adult living donor liver transplant recipients. Transplant Proc. 2004;36:1506\u201311.","journal-title":"Transplant Proc"},{"key":"1038_CR13","first-page":"2674","volume-title":"Drug information for the Health Care Professional 27th","author":"United States Pharmacopeial Convention. USP DI (1)","year":"2007","unstructured":"United States Pharmacopeial Convention. USP DI (1). Drug information for the Health Care Professional 27th. Massachusetts: Thomson Micromedix; 2007. p. 2674\u20139."},{"key":"1038_CR14","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1111\/j.2042-7158.1994.tb03752.x","volume":"46","author":"K Nagase","year":"1994","unstructured":"Nagase K, Iwasaki K, Nozaki K, Noda K. Distribution and protein binding of FK506, a potent immunosuppressive macrolide lactone, in human blood and its uptake by erythrocytes. J Pharm Pharmacol. 1994;46:113\u20137.","journal-title":"J Pharm Pharmacol"},{"key":"1038_CR15","first-page":"610","volume":"25","author":"FS Chow","year":"1997","unstructured":"Chow FS, Piekoszewski W, Jusko WJ. Effect of hematocrit and albumin concentration on hepatic clearance of tacrolimus (FK506) during rabbit liver perfusion. Drug Metab Dispos. 1997;25:610\u20136.","journal-title":"Drug Metab Dispos"},{"key":"1038_CR16","doi-asserted-by":"publisher","first-page":"404","DOI":"10.2165\/00003088-199529060-00003","volume":"29","author":"R Venkataramanan","year":"1995","unstructured":"Venkataramanan R, Swaminathan A, Prasad T, Jain A, Zuckerman S, Warty V, et al. Clinical pharmacokinetics of tacrolimus. Clin Pharmacokinet. 1995;29:404\u201330.","journal-title":"Clin Pharmacokinet"},{"key":"1038_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ejps.2013.10.008","volume":"52","author":"B Golubovi\u0107","year":"2014","unstructured":"Golubovi\u0107 B, Vu\u010di\u0107evi\u0107 K, Radivojevi\u0107 D, Kova\u010devi\u0107 SV, Prostran M, Miljkovi\u0107 B. Total plasma protein effect on tacrolimus elimination in kidney transplant patients\u2013population pharmacokinetic approach. Eur J Pharm Sci. 2014;52:34\u201340.","journal-title":"Eur J Pharm Sci"},{"key":"1038_CR18","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00228-012-1296-4","volume":"69","author":"N Han","year":"2013","unstructured":"Han N, Yun HY, Hong JY, Kim IW, Ji E, Hong SH, et al. Prediction of the tacrolimus population pharmacokinetic parameters according to CYP3A5 genotype and clinical factors using NONMEM in adult kidney transplant recipients. Eur J Clin Pharmacol. 2013;69:53\u201363.","journal-title":"Eur J Clin Pharmacol"},{"key":"1038_CR19","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/clpt.2009.210","volume":"86","author":"W Zhao","year":"2009","unstructured":"Zhao W, Elie V, Roussey G, Brochard K, Niaudet P, Leroy V, et al. Population pharmacokinetics and pharmacogenetics of tacrolimus in de novo pediatric kidney transplant recipients. Clin Pharmacol Ther. 2009;86:609\u201318.","journal-title":"Clin Pharmacol Ther"},{"key":"1038_CR20","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3925\/jjtc.62.641","volume":"62","author":"Y Yonemura","year":"2016","unstructured":"Yonemura Y, Matsumoto M, Inada E, Ueda Y, Ohishi K, Kino S, et al. Guideline for the use of red blood cell products based on scientific evidence. Jpn J Transfus Cell Ther. 2016;62:641\u201350.","journal-title":"Jpn J Transfus Cell Ther"},{"key":"1038_CR21","first-page":"753","volume":"20","author":"M Sattler","year":"1992","unstructured":"Sattler M, Guengerich FP, Yun CH, Christians U, Sewing KF. Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat. Drug Metab Dispos. 1992;20:753\u201361.","journal-title":"Drug Metab Dispos"},{"key":"1038_CR22","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1373\/clinchem.2005.050047","volume":"51","author":"LK Kamdem","year":"2005","unstructured":"Kamdem LK, Streit F, Zanger UM, Brockm\u00f6ller J, Oellerich M, Armstrong VW, et al. Contribution of CYP3A5 to the in vitro hepatic clearance of tacrolimus. Clin Chem. 2005;51:1374\u201381.","journal-title":"Clin Chem"},{"key":"1038_CR23","doi-asserted-by":"publisher","first-page":"328","DOI":"10.2133\/dmpk.22.328","volume":"22","author":"K Iwasaki","year":"2007","unstructured":"Iwasaki K. Metabolism of tacrolimus (FK506) and recent topics in clinical pharmacokinetics. Drug Metab Pharmacokinet. 2007;22:328\u201335.","journal-title":"Drug Metab Pharmacokinet"},{"key":"1038_CR24","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1067\/mcp.2002.129304","volume":"72","author":"CE Staatz","year":"2002","unstructured":"Staatz CE, Willis C, Taylor PJ, Tett SE. Population pharmacokinetics of tacrolimus in adult kidney transplant recipients. Clin Pharmacol Ther. 2002;72:660\u20139.","journal-title":"Clin Pharmacol Ther"},{"key":"1038_CR25","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/aps.2014.110","volume":"36","author":"YX Lu","year":"2015","unstructured":"Lu YX, Su QH, Wu KH, Ren YP, Li L, Zhou TY, et al. A population pharmacokinetic study of tacrolimus in healthy Chinese volunteers and liver transplant patients. Acta Pharmacol Sin. 2015;36:281\u20138.","journal-title":"Acta Pharmacol Sin"},{"key":"1038_CR26","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1038\/sj.bmt.1703224","volume":"28","author":"P Jacobson","year":"2001","unstructured":"Jacobson P, Ng J, Ratanatharathorn V, Uberti J, Brundage RC. Factors affecting the pharmacokinetics of tacrolimus (FK506) in hematopoietic cell transplant (HCT) patients. Bone Marrow Transplant. 2001;28:753\u20138.","journal-title":"Bone Marrow Transplant"},{"key":"1038_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1083-8791(98)50005-5","volume":"4","author":"JR Wingard","year":"1998","unstructured":"Wingard JR, Nash RA, Przepiorka D, Klein JL, Weisdorf DJ, Fay JW, et al. Relationship of tacrolimus (FK506) whole blood concentrations and efficacy and safety after HLA-identical sibling bone marrow transplantation. Biol Blood Marrow Transplant. 1998;4:157\u201363.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1038_CR28","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1053\/bbmt.1999.v5.pm10371361","volume":"5","author":"D Przepiorka","year":"1999","unstructured":"Przepiorka D, Nash RA, Wingard JR, Zhu J, Maher RM, Fitzsimmons WE, et al. Relationship of tacrolimus whole blood levels to efficacy and safety outcomes after unrelated donor marrow transplantation. Biol Blood Marrow Transplant. 1999;5:94\u20137.","journal-title":"Biol Blood Marrow Transplant"},{"key":"1038_CR29","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med. 1999;130:461\u201370.","journal-title":"Ann Intern Med"},{"key":"1038_CR30","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1373\/clinchem.2006.077180","volume":"53","author":"AS Levey","year":"2007","unstructured":"Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, Chronic Kidney Disease Epidemiology Collaboration, et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53:766\u201372.","journal-title":"Clin Chem"},{"key":"1038_CR31","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Collaborators developing the Japanese equation for estimated GFR, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982\u201392.","journal-title":"Am J Kidney Dis"},{"key":"1038_CR32","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.2215\/CJN.01640309","volume":"4","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Work DF. Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol. 2009;4:1832\u201343.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1038_CR33","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1046\/j.1365-2125.2003.02008.x","volume":"57","author":"H Zahir","year":"2004","unstructured":"Zahir H, McCaughan G, Gleeson M, Nand RA, McLachlan AJ. Factors affecting variability in distribution of tacrolimus in liver transplant recipients. Br J Clin Pharmacol. 2004;57:298\u2013309.","journal-title":"Br J Clin Pharmacol"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-020-01038-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11096-020-01038-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-020-01038-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:27:42Z","timestamp":1619569662000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11096-020-01038-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,28]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1038"],"URL":"https:\/\/doi.org\/10.1007\/s11096-020-01038-9","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,28]]},"assertion":[{"value":"21 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}